BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 17690553)

  • 1. Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt-Jakob disease.
    Satoh K; Shirabe S; Tsujino A; Eguchi H; Motomura M; Honda H; Tomita I; Satoh A; Tsujihata M; Matsuo H; Nakagawa M; Eguchi K
    Dement Geriatr Cogn Disord; 2007; 24(3):207-12. PubMed ID: 17690553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronological changes in MRI and CSF biochemical markers in Creutzfeldt-Jakob disease patients.
    Satoh K; Shirabe S; Eguchi H; Tsujino A; Motomura M; Satoh A; Tsujihata M; Eguchi K
    Dement Geriatr Cogn Disord; 2007; 23(6):372-81. PubMed ID: 17389797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cerebrospinal fluid proteins as early diagnostic markers for sporadic Creutzfeldt-Jakob disease.
    Pennington C; Chohan G; Mackenzie J; Andrews M; Will R; Knight R; Green A
    Neurosci Lett; 2009 May; 455(1):56-9. PubMed ID: 19429106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Laboratory and imaging studies for the diagnosis of prion disease].
    Shiga Y; Miyazawa K; Takeda A; Arai H; Doh-ura K; Itoyama Y
    Rinsho Shinkeigaku; 2003 Nov; 43(11):810-2. PubMed ID: 15152471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follow-up investigations of tau protein and S-100B levels in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.
    Cepek L; Steinacker P; Mollenhauer B; Wiese B; Ciesielczyk B; Bibl M; Wiltfang J; Zerr I; Schulz-Schaeffer W; Kretzschmar HA; Poser S; Otto M
    Dement Geriatr Cogn Disord; 2005; 19(5-6):376-82. PubMed ID: 15802913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of 14-3-3beta immunoblot and T-tau/P-tau ratio in clinically suspected Creutzfeldt-Jakob disease.
    Blennow K; Johansson A; Zetterberg H
    Int J Mol Med; 2005 Dec; 16(6):1147-9. PubMed ID: 16273298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glial fibrillary acidic protein and protein S-100B: different concentration pattern of glial proteins in cerebrospinal fluid of patients with Alzheimer's disease and Creutzfeldt-Jakob disease.
    Jesse S; Steinacker P; Cepek L; von Arnim CA; Tumani H; Lehnert S; Kretzschmar HA; Baier M; Otto M
    J Alzheimers Dis; 2009; 17(3):541-51. PubMed ID: 19433893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease.
    Van Everbroeck B; Boons J; Cras P
    Clin Neurol Neurosurg; 2005 Aug; 107(5):355-60. PubMed ID: 16023527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance spectroscopy and measurement of tau epitopes of autopsy proven sporadic Creutzfeldt-Jakob disease in a patient with non-specific initial EEG, MRI and negative 14-3-3 immunoblot.
    Sarac H; Hajnsek S; Basić S; Henigsberg N; Rados M; Simić G
    Coll Antropol; 2008 Jan; 32 Suppl 1():199-204. PubMed ID: 18405083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion-weighted MRI in Creutzfeldt-Jakob disease: a better diagnostic marker than CSF protein 14-3-3?
    Mendez OE; Shang J; Jungreis CA; Kaufer DI
    J Neuroimaging; 2003 Apr; 13(2):147-51. PubMed ID: 12722497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt-Jakob disease.
    Krasnianski A; Meissner B; Schulz-Schaeffer W; Kallenberg K; Bartl M; Heinemann U; Varges D; Kretzschmar HA; Zerr I
    Arch Neurol; 2006 Jun; 63(6):876-80. PubMed ID: 16769870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias.
    Riemenschneider M; Wagenpfeil S; Vanderstichele H; Otto M; Wiltfang J; Kretzschmar H; Vanmechelen E; Förstl H; Kurz A
    Mol Psychiatry; 2003 Mar; 8(3):343-7. PubMed ID: 12660807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease.
    Buerger K; Otto M; Teipel SJ; Zinkowski R; Blennow K; DeBernardis J; Kerkman D; Schröder J; Schönknecht P; Cepek L; McCulloch C; Möller HJ; Wiltfang J; Kretzschmar H; Hampel H
    Neurobiol Aging; 2006 Jan; 27(1):10-5. PubMed ID: 16298235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and diagnosis of dura mater graft associated Creutzfeldt Jakob disease.
    Noguchi-Shinohara M; Hamaguchi T; Kitamoto T; Sato T; Nakamura Y; Mizusawa H; Yamada M
    Neurology; 2007 Jul; 69(4):360-7. PubMed ID: 17646628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CSF-analyses in clinical diagnosis of Creutzfeldt-Jakob disease. A literature review and three cases from routine clinical practice].
    Blennow K; Lind B; Andersson E; Andreasen N
    Lakartidningen; 2001 May; 98(20):2446-51. PubMed ID: 11433975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease.
    Sanchez-Juan P; Green A; Ladogana A; Cuadrado-Corrales N; Sáanchez-Valle R; Mitrováa E; Stoeck K; Sklaviadis T; Kulczycki J; Hess K; Bodemer M; Slivarichová D; Saiz A; Calero M; Ingrosso L; Knight R; Janssens AC; van Duijn CM; Zerr I
    Neurology; 2006 Aug; 67(4):637-43. PubMed ID: 16924018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 14-3-3 protein levels and isoform patterns in the cerebrospinal fluid of Creutzfeldt-Jakob disease patients in the progressive and terminal stages.
    Shiga Y; Wakabayashi H; Miyazawa K; Kido H; Itoyama Y
    J Clin Neurosci; 2006 Jul; 13(6):661-5. PubMed ID: 16815706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinically atypical CJD: diagnostic relevance of cerebrospinal fluid markers and molecular genetic analysis?].
    Tumani H; Windl O; Kretzschmar HA; Ludolph AC
    Dtsch Med Wochenschr; 2002 Feb; 127(7):318-20. PubMed ID: 11845387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease.
    Brechlin P; Jahn O; Steinacker P; Cepek L; Kratzin H; Lehnert S; Jesse S; Mollenhauer B; Kretzschmar HA; Wiltfang J; Otto M
    Proteomics; 2008 Oct; 8(20):4357-66. PubMed ID: 18814332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease.
    Green AJ; Thompson EJ; Stewart GE; Zeidler M; McKenzie JM; MacLeod MA; Ironside JW; Will RG; Knight RS
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):744-8. PubMed ID: 11385008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.